Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analyzing the "correct" endpoint.

Pamela J Atherton1, Paul J Novotny, Angelina D Tan

  • 1Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA.

Current Problems in Cancer
|November 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safely Stopping Premedications in Patients Receiving Paclitaxel: A Randomized Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Medication adherence in thoracic transplant candidates.

Frontiers in psychology·2026
Same author

Impact of a web-based breast cancer surgery decision aid on knowledge and perceptions of feeling informed in clinics that care for socioeconomically disadvantaged patients: An Alliance Clinical Trial (A231701CD).

Cancer·2026
Same author

Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Beyond Physical Frailty-the Value of Lifestyle and Social Frailty Factors to Predict Mortality and Hospitalization in COPD.

Journal of cardiopulmonary rehabilitation and prevention·2025
Same author

Impact of a Web-Based Decision Aid on Socioeconomically Disadvantaged Patients' Engagement in Breast Surgery Decision-Making: Stepped-Wedge Clinical Trial (Alliance-A231701CD).

Annals of surgical oncology·2025
Same journal

Clinical impact of a single time-point protocol paired FDG-PET and radioactive iodine scan for comprehensive disease assessment in differentiated thyroid cancer.

Current problems in cancer·2026
Same journal

Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database.

Current problems in cancer·2026
Same journal

Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer.

Current problems in cancer·2026
Same journal

Artificial intelligence, omics, and biomarkers: Redefining lung cancer early detection.

Current problems in cancer·2026
Same journal

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.

Current problems in cancer·2026
Same journal

Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer.

Current problems in cancer·2026
See all related articles

Choosing quality of life (QOL) endpoints requires considering potential treatment effects, data completeness, and statistical power. Proper selection and analysis of QOL endpoints ensure reliable study outcomes.

Area of Science:

  • Health Outcomes Research
  • Clinical Trial Design
  • Patient-Reported Outcomes

Background:

  • Quality of Life (QOL) is a critical measure in clinical research.
  • Effective QOL assessment requires careful endpoint selection and methodology.

Purpose of the Study:

  • To provide guidance on selecting appropriate Quality of Life (QOL) endpoints for clinical studies.
  • To outline considerations for calculating QOL changes and ensuring statistical validity.

Main Methods:

  • Endpoint selection should prioritize scores sensitive to favorable treatment effects.
  • Calculation methods must account for missing data, data collection frequency, and outlier impact.
  • Statistical power is essential to detect meaningful differences (e.g., 10 points on a 0-100 scale).

Related Experiment Videos

Main Results:

  • The choice of QOL endpoint significantly influences the ability to detect treatment benefits.
  • Methodological choices in data analysis impact the reliability of QOL findings.
  • Sufficient statistical power is a prerequisite for meaningful QOL endpoint interpretation.

Conclusions:

  • Selecting the right QOL endpoint and analysis method is crucial for robust clinical trial results.
  • Secondary endpoints can supplement and confirm primary QOL findings, enhancing overall study interpretation.